DNDi and Cipla to develop four-in-one pediatric antiretroviral drug combination
Friday, July 20, 2012 - 21:00
in Health & Medicine
Researchers are working to develop and produce an improved first-line antiretroviral combination therapy specifically adapted to meet the treatment needs of the youngest children living with HIV/AIDS.